Home » Topics » Conferences

Conferences
RSS

New AGE production inhibitor with promise in diabetic nephropathy

July 3, 2001

ADA news: glycemic control and lipid profiles improve on INS-1 + sulfonylurea in type 2 diabetes

July 3, 2001

Additional beneficial effects emerge for SERM Sch-57068 (EM-652) in preclinical studies

July 3, 2001

Further study of zonisamide for migraine/headache prophylaxis appears appropriate

July 3, 2001

COX-2 inhibitor, leukotriene receptor antagonist and their combination useful for migraine

July 3, 2001

Adjunctive therapy with tizanidine for migraine prophylaxis

July 2, 2001

Potential of topiramate for diabetes explored using animal models

July 2, 2001

Prophylaxis of refractory migraine with levetiracetam discussed at IHC 2001

July 2, 2001

BIBN-4096BS is a functionally selective CGRP receptor antagonist with potential in migraine Rx

July 2, 2001

Further results for NN-2211 continue to support its potential in type 2 diabetes

July 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...